You are here: Home » Current Affairs » Coronavirus » News
Business Standard

South Africa to store Covid-19 vaccines from India at secret place

The South African government will store the 1.5 million doses of the Covid-19 vaccine that it will receive from India in the next few weeks at a secret place because of the risk of theft

South Africa | Coronavirus Vaccine | India

Press Trust of India  |  Johannesburg 

AstraZeneca wasn't the obvious choice to partner up with Oxford when scientists there started developing a coronavirus shot. Photographer: Mikael Sjoberg/Bloomberg
Covid-19 vaccines

The South African government will store the 1.5 million doses of the COVID-19 vaccine that it will receive from in the next few weeks at a secret place because of the risk of theft for sale at black market prices, according to a media report.

The vaccines are a highly-rated commodity once they're stolen and reach the black market, Department of Health spokesperson Popo Maja told the weekly City Press on Sunday, adding that if this occurs, there is a risk that the prices of these illegally-obtained vaccines will be hiked significantly.

There will be a central place where the consignment will be stored and from where we will distribute it to hospital and clinic pharmacies that can store it, Maja said.

There's a security issue too because countries which have already begun rolling out the vaccines have warned us that there is a huge theft of it, so we may not even disclose where it is being centrally stored, Maja said.

Health Minister Zweli Mkhize said during an address to the South African parliament last week, that the government had secured 1.5 million doses of the AstraZeneca COVID-19 vaccine from as battles exponentially rising infections and deaths daily amid a second wave of the and a new variant of the virus.

Overnight on Sunday there were over 21,600 new infections and 399 more deaths.

A million doses are expected from before the end of this month and a further 500,000 in February, with healthcare workers in both government and private facilities being prioritised for vaccination.

Mkhize also allayed concerns that the vaccine to be supplied by India had not yet been approved by South African regulators.

He said teams from the department of health as well as the South African Health Products Regulatory Authority (SAHPRA) were fine-tuning and aligning all the regulations and processes to ensure that there were no unnecessary delays or impediments to rollout the vaccine.

We are all happy that the Serum Institute of India and the AstraZeneca vaccine have already been approved by various regulators and is being rolled out in other countries, he said.

Addressing concerns that corruption might make the process costly, as had been the case in the provision of Personal Protective Equipment (PPE) to health workers for months during the COVID-19 lockdown, Mkhize gave an assurance that there would be no corruption as the deal was being done directly between the government and the manufacturer, unlike the middlemen used in the PPE acquisitions who had exploited the situation.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, January 11 2021. 07:20 IST